Nutriband
Develops transdermal drug products centered on its AVERSA abuse-deterrent patch technology.
$4.46
After-hours close−0.01 (−0.22%)
At close$4.47(−3.25%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 3.08%374.2K sharesInsiders 14.49%1.76M sharesOther 82.43%10.02M shares
Shares outstanding 12.16M · Float 5.28M · 43.4% free float
Institutions13F, as of Mar 31, 2026
14 holders · 374.2K shares · 3 new positions · 6 increased · 3 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 174.9K | 1.44% | +174.9Knew | May 15, 2026 |
| Geode Capital Management, LLC | 70.1K | 0.58% | +10.1K | May 15, 2026 |
| UBS Group AG | 32.7K | 0.27% | +31.4K | May 5, 2026 |
| Vanguard Fiduciary Trust Co | 25.1K | 0.21% | +25.1Knew | May 8, 2026 |
| State Street Corp | 25.0K | 0.21% | 0 | May 15, 2026 |
| Northern Trust Corp | 13.9K | 0.11% | 0 | May 14, 2026 |
| Haven Private, LLC | 11.4K | 0.09% | −60 | May 5, 2026 |
| BlackRock, Inc. | 9.5K | 0.08% | +767 | May 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vitale Botgrosincl. T.I.I. - Jetservices, Lda, Nociata Holding Limited | 32.37% | 4.18M | 13D/A | Sep 19, 2024 ↗ |
| Gareth Sheridan | 17.73% | 2.01M | 13D | Mar 13, 2025 ↗ |
| Serguei Melnik | 9.39% | 1.07M | 13D | Mar 13, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Gareth Sheridan | director, 10 percent owner, officer: Chief Executive Officer | 1.76M | 14.49% | Nov 25, 2025 |
2 people have not refiled in the last 18 months (829.5K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.